Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
As of: Nov 16, 2026 · 3:54 PM EST

Elite Pharmaceuticals (ELTP) FCF Margin (2009 - 2026)

Updated

Elite Pharmaceuticals' FCF Margin was -9.50% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 23.27 percentage points from 13.77% a year earlier and down 38.12 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) FCF Margin (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Elite Pharmaceuticals' FCF Margin was 6.02% through Sep 30, 2026, down 11.60 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 15.33%, up 8.39 percentage points from FY2025.

  • FCF Margin shows a five-year change of +4.05 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, FCF Margin was 6.94% in FY2025 (+14.08 pp), -7.14% in FY2024 (-0.12 pp), -7.02% in FY2023 (-25.65 pp) and 18.63% in FY2022 (+7.34 pp).
  • Quarterly FCF Margin has moved between -42.04% (fiscal Q2 2023) and 36.20% (fiscal Q1 2026) over five years.
  • Compared with a year earlier, FCF Margin was higher in five of the last eight quarters, with an average year-over-year change of +1.17 percentage points.
  • The best year-over-year quarter for FCF Margin over five years was fiscal Q1 2025 (a gain of 42.76 percentage points); the worst was fiscal Q2 2023 (a drop of 42.12 percentage points).
  • Per Business Quant data, ELTP's FCF Margin in the three fiscal quarters before Q2 2027 was 28.62% (Q1 2027), 21.47% (Q4 2026) and -17.36% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 25.03%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 41.97%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.51%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 52.85%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.25%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 57.81%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 28.96%
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn -9.50%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -9.50%
Jun 30, 2026 28.62%
Mar 31, 2026 21.47%
Dec 31, 2025 -17.36%
Sep 30, 2025 13.77%
Jun 30, 2025 36.20%
Mar 31, 2025 9.89%
Dec 31, 2024 -7.41%
Sep 30, 2024 7.23%
Jun 30, 2024 12.58%
Mar 31, 2024 9.45%
Dec 31, 2023 -15.37%
Sep 30, 2023 -1.67%
Jun 30, 2023 -30.18%
Mar 31, 2023 28.15%
Dec 31, 2022 -6.15%
Sep 30, 2022 -42.04%
Jun 30, 2022 -8.50%
Mar 31, 2022 17.48%
Dec 31, 2021 32.89%
API Access

Elite Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ELTP&period=max&api_key=YOUR_API_KEY